J. Li

Frequency of S492R Mutations in the Epidermal Growth Factor Receptor: Analysis of Plasma Dna from Metastatic Colorectal Cancer Patients Treated with Panitumumab or Cetuximab Monotherapy

Kathryn J. Newhall, Timothy Price, Marc Peeters et al. · Annals of Oncology · 2014 · 23 citations · Full text

Medicine, Genetics, Oncology +11

Phase III Study of Apatinib in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial

J. Li, Shu-Kui Qin, Jianming Xu et al. · Annals of Oncology · 2014 · 21 citations · Full text

Medicine, Oncology, Pharmacology +8

Impact of tumor epidermal growth factor receptor (EGFR) status on the outcomes of first-line FOLFOX-4 ± cetuximab in patients (pts) with RAS-wild-type (wt) metastatic colorectal cancer (mCRC) in the randomized phase 3 TAILOR trial

Shukui Qin, Jianming Xu, L. Wang et al. · Annals of Oncology · 2016 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17

Concur: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Regorafenib Monotherapy in Asian Patients with Previously Treated Metastatic Colorectal Cancer (MCRC)

J. Li, S. Qin, Thomas Yau et al. · Annals of Oncology · 2014 · 11 citations

Medicine, Oncology, Pharmacology +10